Sort
51,593 grants matching “hepatitis”
HIV Infection in Drug Users in Two International Sites
$546,115Sherwood L Gorbach · Tufts University Boston · R01 · FY2009 · DA
ENTEROHEPATIC LIPID FLUX AND APOPROTEIN BIOSYNTHESIS
$546,093Nicholas Davidson · Washington University · R01 · FY2013 · HL
Mechanisms of Venous Thromboembolism in Cancer
$546,028Nigel Mackman · Univ Of North Carolina Chapel Hill · R01 · FY2012 · HL
Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV)
$546,000Judy L Aschner · Vanderbilt University · U01 · FY2012 · HL
Seq-Scope: Microscopic Examination of Spatial Single Cell Transcriptome in Cell and Tissue Senescence
$546,000Jun Hee Lee · University Of Michigan At Ann Arbor · UG3 · FY2022 · CA
Seq-Scope: Microscopic Examination of Spatial Single Cell Transcriptome in Cell and Tissue Senescence
$546,000Jun Hee Lee · University Of Michigan At Ann Arbor · UG3 · FY2021 · CA
Towards Translation of MU-CN29: New Therapeutic Nanoparticle for Drug-Resistant NSCLC
$545,975Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2024 · CA
Mechanisms of neutrophil extracellular trap formation and contribution to biliary fibrosis in biliary atresia
$545,972Cara Lynn Mack · Medical College Of Wisconsin · R01 · FY2024 · DK
Mechanisms of neutrophil extracellular trap formation and contribution to biliary fibrosis in biliary atresia
$545,972Cara Lynn Mack · Medical College Of Wisconsin · R01 · FY2025 · DK
Fecal microbiota transplant for Alcohol-Associated Cirrhosis
$545,966Jasmohan S Bajaj · Virginia Commonwealth University · R01 · FY2023 · AA
VIRAL HEPATITIS-PREVENTION & SURVEILLANCE
$545,939Anne M Brenner · Washington State Department Of Health · U51 · FY2014 · PS
Brain Amyloid and HAND in the cART era
$545,930Cristian L Achim · University Of California, San Diego · R01 · FY2015 · MH
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$545,928Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Trans-acting Factors Causing Cell Specific Gene Control
$545,915Kenneth S Zaret · University Of Pennsylvania · R37 · FY2012 · GM
Trans-acting Factors Causing Cell Specific Gene Control
$545,915Kenneth S Zaret · University Of Pennsylvania · R37 · FY2014 · GM
Trans-acting Factors Causing Cell Specific Gene Control
$545,915Kenneth S Zaret · University Of Pennsylvania · R37 · FY2015 · GM
Trans-acting Factors Causing Cell Specific Gene Control
$545,914Kenneth S Zaret · University Of Pennsylvania · R37 · FY2011 · GM
Environmental Obesogens and Weight Change in the POUNDS LOST Trial
$545,909Qi Sun · Harvard School Of Public Health · R01 · FY2015 · ES
Multi-level Evaluation of Racial/ethnic Disparities in Liver Disease Outcomes
$545,848Fasiha Kanwal · Baylor College Of Medicine · R01 · FY2022 · CA
Sustainable HIV Risk Reduction Strategies for CJ Systems
$545,835Wayne E.k. Lehman · Texas Christian University · R01 · FY2016 · DA
Safety and Effectiveness of Medications for Alcohol Use Disorder among HIV+/-
$545,777E. Jennifer Edelman · Yale University · P01 · FY2021 · AA
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska
$545,775Robert L Carithers · University Of Washington · U01 · FY2012 · DK
MICHIGAN DEPT. OF COMMUNITY HEALTH VIRAL HEPATITIS PREVENTION COORDINATION & SURE
$545,722Kathryn Emery Macomber · Michigan State Department Of Health And Human Services · U51 · FY2014 · PS
Fibroblast growth factor 1 prevents hyperlipidemia and atherosclerosis
$545,630Yi Tan · University Of Louisville · R01 · FY2023 · HL
Orally Active Nucleoside Phosphonates for Hepatitis C Virus
$545,533Robert Turner Schooley · University Of California, San Diego · R01 · FY2012 · AI